Keyphrases
Plantar Flexors
94%
18F-FLT
94%
Electromyography
71%
Gait
71%
18F-fluorodeoxyglucose (18F-FDG)
66%
Ovarian Cancer
62%
Ankle muscles
59%
Sensory Feedback
59%
Ankle Plantar Flexors
53%
Treatment Monitoring
52%
Human Ovary
52%
Cancer Xenograft
52%
Treatment Response
47%
Human Ovarian Cancer
47%
Belinostat
47%
Muscle Activation
47%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
47%
Psoriasis
47%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
47%
Nicotinamide Phosphoribosyltransferase (NAMPT)
47%
APO866
47%
Dexrazoxane
47%
Xenograft Tumor
47%
Carboplatin
47%
Visually Guided Walking
47%
Central Nervous System Tumors
47%
Etoposide
47%
Common Drive
47%
Cutaneous Feedback
47%
Error Signal
47%
Perturbed Walking
47%
Radiotherapy
47%
Locomotor Adaptation
47%
Visually Guided
47%
Male Gymnasts
47%
Dorsiflexor muscles
47%
Synergize
47%
Paclitaxel
47%
Locomotor
47%
Tonic
47%
Positron Emission Tomography
47%
Sequence Learning
47%
Corticomuscular
47%
Human Xenografts
47%
Muscle Contraction
47%
Soleus
41%
Healthy Adults
40%
Push-off
35%
Tibialis Anterior
35%
Age-related
35%
Medicine and Dentistry
Fluorodeoxyglucose F 18
100%
Fluorine-18
100%
Ovarian Cancer
99%
Tumor Xenograft
99%
Neoplasm
98%
Polyethylene Terephthalate
94%
positron emission tomographic scan
57%
Non Invasive Procedure
47%
Belinostat
47%
Psoriasis
47%
Nicotinamide Phosphoribosyltransferase
47%
Daporinad
47%
Framingham Risk Score
47%
Etoposide
47%
Central Nervous System Tumor
47%
Radiation Therapy
47%
Patient Monitoring
47%
Carboplatin
47%
Drive
47%
Paclitaxel
47%
Electromyography
47%
Xenograft
47%
Treatment Response
47%
Radioactive Tracer
30%
Gastrocnemius
23%
Repetitive Nerve Stimulation
23%
Orthosis
23%
Plantar Nerve
23%
Cell Proliferation
20%
Prevalence
20%
Population
20%
Treatment Group
17%
Glucose Uptake
15%